Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201207064 Principal Investigator: Westervelt, Peter
Title: A Phase II Controlled Trial of a Single Prohema-CB unit(Ex Vivo Modulated Human Cord Blood Cells)As Part of a Double Umbilical Cord Blood Transplant Following Myeloablative or Reduced Intensity Conditioning For Patients Age 15-65 Years With Hematologic Malignancies
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to determine the effects of the ProHema-CB treatment on umbilical cord blood units to be used in transplantation. ProHema-CB treatment is being tested to see if it can improve the ability of umbilical cord blood stem cells to grow after transplantation.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)